Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Smith

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2011
Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence settingA C Pettit, L A Kaltenbach, F Maruri, et al.
Headache|April 25, 2001
Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraineF G Freitag, R Cady, F DiSerio, et al.
Clinical Neurology and Neurosurgery|June 30, 2018
Depression and survival of glioma patients: A systematic review and meta-analysisC Shi, Nayan Lamba, L J Zheng, et al.
Acta Neurochirurgica|August 7, 2017
Innovation in neurosurgery: less than IDEAL? A systematic reviewI S Muskens, S J H Diederen, J T Senders, et al.
Clinical and Translational Radiation Oncology|June 30, 2020
Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumoursS H J Nagtegaal, A F C Hulsbergen, E B L van Dorst, et al.
International Journal of Clinical Practice|August 16, 2003
Establishing principles for migraine management in primary careA J Dowson, J Sender, S Lipscombe, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Environment International|February 17, 2022
Wastewater-based epidemiology in hazard forecasting and early-warning systems for global health risksB Kasprzyk-Hordern, B Adams, I D Adewale, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2011
Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence settingA C Pettit, L A Kaltenbach, F Maruri, et al.
Headache|April 25, 2001
Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraineF G Freitag, R Cady, F DiSerio, et al.
Clinical Neurology and Neurosurgery|June 30, 2018
Depression and survival of glioma patients: A systematic review and meta-analysisC Shi, Nayan Lamba, L J Zheng, et al.
Acta Neurochirurgica|August 7, 2017
Innovation in neurosurgery: less than IDEAL? A systematic reviewI S Muskens, S J H Diederen, J T Senders, et al.
Clinical and Translational Radiation Oncology|June 30, 2020
Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumoursS H J Nagtegaal, A F C Hulsbergen, E B L van Dorst, et al.
International Journal of Clinical Practice|August 16, 2003
Establishing principles for migraine management in primary careA J Dowson, J Sender, S Lipscombe, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Environment International|February 17, 2022
Wastewater-based epidemiology in hazard forecasting and early-warning systems for global health risksB Kasprzyk-Hordern, B Adams, I D Adewale, et al.
Pageof 12